MERCURY HEALTHCARE PVT LTD

Mumbai-based Mercury Healthcare recorded a revenue generation of Rs 19 crore in the biopharma space in FY 20-21, showing a slight growth when compared to the revenue generation of Rs 18 crore during FY 19-20. The company manufactures stable and therapeutically effective formulations in independent manufacturing facilities across India. The product portfolio ranges from tablets, capsules (hard and soft gelatin), syrups (liquid and dry), eye and ear drops, injectables, ointments and creams, inhalers to veterinary tablets. The products also include surgical gloves, absorbent cotton, syringes, needles etc.